Conference 4th Pharmacovigilance 2013

CompanyProfileandconferences.com promote a new conference on "4th Pharmacovigilance 2013" gives information about Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market.

Conference on 4th Pharmacovigilance 2013 To be held on 12th to13th March 2013 at Hotel Marriott, London UK

CONFERENCE INTRODUCTION:-

It is estimated that the average spend on pharmacovigilance is 6% to 13% of a companies total R&D. From product development in clinical trials to post marketing surveillance, adverse drug reactions are monitored and safety signals investigated. The new legislation includes sweeping changes that leave industry with a lot of questions. If you want to file your product in Europe (MAA), what new PV regulatory processes do you need to put in place? Will the Pharmacovigilance System Master File be useful? And what is really meant by a Quality Management System?

The Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the ke issues of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of case studies and industry experiences.

4th Pharmacovigilance 2013 is the latest in Virtue Insight's series of successful pharmacovigilance events. Also it can help you control your product's lifecycle, your patient's trust, and your revenue. Hence, 4th Pharmacovigilance 2013 will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting pharmacovigilance Market development.

It gives me great pleasure in welcoming all of you to the Virtue Insight's I wish and pray that all our efforts
will be beneficial to our industries and to our country at large.

KEY THEMES DISCUSSED AT THIS CONFERENCE:-

Exploiting the latest technologies, methodologies and introducing pharmacy automations on work practices of Pharmacovigilance in EU, US and Asia
• Impact of the new European Pharmacovigilance legislation - Implementation and Beyond
• Keeping abreast of the changes impacting the drug safety industry to ensure the pharmacovigilance strategies are robust and geared to compliance
• Recent successful strategies and business models to bring out new medicines
• How will PV activities change with Clinical Trial Transformation Initiative?
• Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
• Identifying essential antidote requirements and learn to implement best practices in drug safety and surveillance
• Exploiting the pharmacy automations and technologies for enhancement of medication safety
• Impact of technology – learn and explore
• Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
• Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
• Determining the steps and strategies for enhancing quality in healthcare

For more information kindly visit :  4th Pharmacovigilance 2013                       

Or

Contact us at :

Company Profiles And Conferences
Phone : + 91 22 27812707
Fax : + 91 22 27812290
E-mail : info@companyprofilesandconferences.com
Website : www.companyprofilesandconferences.com
 

Conference on 2nd Biosimilars Congregation 2013

CompanyProfileandconferences.com promote a new conference on "2nd Biosimilars Congregation 2013" which discuss on Commercial challenges, opportunities and strategies to develop Biosimilars.

 2nd Biosimilars Congregation 2013 To be held on 19th and 20th Feb 2013 at Marriott Hotel , London UK

 According to Global Industry Analysts Inc.. The global market for biosimilars is forecast to reach US$4.8 billion by the year 2015. By 2020, some $55 Billion worth of biologic patents are due to expire. Key factors driving market growth include patent expiries of key biological drugs, cost containment measures from governments, aging population, and supporting legislations. The recent establishment of regulatory guidelines for biosimilars in the US is expected to add further momentum to the growth of the global biosimilars market. Increasing pressure from governments and insurers for greater biologic competition, there exists an incredible opportunity for biosimilar producers to capitalise on what is set to become the fastest growing sector of the pharmaceutical industry. http://www.companyprofilesandconferences.com/seminars-conferences/Pharmaceuticals-Healthcare-c13/2nd-Biosimilars-Congregation-2013.html

 The barriers to entry for this lucrative market however require that companies establish and harmonise carefully planned regulatory, clinical and marketing strategies. Innovators and biosimilar applicants need to find answers to the current myriad of commercialisation questions that face the market. Those to establish their market presence first will dictate the success of companies in the biosimilar space.

 Europe holds the highest number of biosimilar approvals, and this number will continue to increase in the near future. Further biologic patent expiries will boost the number of biosimilars to be approved, thereby bringing in an increased number of products that will help increase market size and competition among market participants. The biosimilars market is in the nascent stage of the industry life cycle with limited market and product development experience. However, there is a significant market opportunity from patent expiries. High initial investments are still a major barrier for new entrants. Collaborations among large pharmaceutical companies with financial capabilities and specialty biotech companies with technical expertise are expected. The strong integration of marketing and research and development skills is the key to success in the biosimilars market.

 The Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Hence, this 3rd Biosimilars Congregation 2013 will look at the multiple facets of biosimilars, ranging from the evolving regulatory landscape and challenges in clinical development, to the legal and economic aspects. By attending this conference you will gain a comprehensive outlook on the key issues surrounding biosimilars. This event will provide an important platform for Biosimilars stakeholders to discuss and share best practices in expediting Biosimilars development.

 Key Speakers Include:-
 Paul Tredwell, Head of Biopharmaceuticals, Sandoz
 Anne Cook, Biologicals Quality Assessor, MHRA
 Cecil Nick, Vice President, Biotechnology, Parexel
 Yariv Hefez, Vice President Business Development & Alliance Management, Biosimilars, Merck Serono
 Alex Kudrin, Medical Assessor in Licensing of Biological Products, MHRA (Former Medical Director,Takeda Pharmaceuticals )
 Malcolm I Mitchell, Senior Medical Fellow, Clinical Pharmacology, Eli Lilly

 For more information kindly visit :  http://www.companyprofilesandconferences.com/seminars-conferences/Pharmaceuticals-Healthcare-c13/2nd-Biosimilars-Congregation-2013.html                         

 Or

 Contact us at :

 Company Profiles And Conferences
 Phone: +91 22 27810772, 27810773
 Fax: +91 22 27810778
 Email : info@companyprofilesandconferences.com
 Website : www.companyprofilesandconferences.com/
 Our Blogs : http://www.companyprofilesandconferences.com/blog/
 

Middle East Engineering Procurement Construction Conference 2012

CompanyProfileandconferences.com promote a new conference on "Middle East Engineering Procurement Construction Conference 2012"  focused for EPC Contractors and allied business.

 Middle East Engineering Procurement Construction Conference 2012 To be held on 3rd and 4th Dec 2012 at Hilton Abu Dhabi

 Conference Description
 Time: 8:30am to 5:30pm (both days)

 Annual EPC Sphere Middle East 2012 Conference will provide executives and decision makers from across Middle East and around the globe with the opportunity to interact with industry thought leaders and peers. This 2 – day conference will include world-class keynote speakers on trends and strategies, latest solutions and technology, equipment update and extensive opportunities for networking. http://www.companyprofilesandconferences.com/seminars-conferences/Manufacturing-Construction-c24/Middle-East-Engineering-Procurement-Construction-Conference-2012.html

 The program will reflect the rapid changes in the global economy and the engineering & construction industry, and ensuring that topics are timely and reflect the latest thought leadership. Conference is expected to be attended by more than 200 + senior level executives from EPC companies, Technology and Solution Providers, Owner Companies, investment companies and knowledge firms making it a perfect business forum for knowledge sharing and networking. This is the first of its kind forum for Middle East sector specially focused for EPC Contractors and allied business.

 Key Subjects:

 • Public Private Partnership – Outlook for Middle East Region
 • EPC Contracting in Middle East - Vision 2030
 • Conditions in Projects Implementations – Regional Perspective
 • Latest EPC Contracting Formats - A Perpetual Improvement Process
 • Updates on Latest Technology for Infrastructure Sector
 • Updates on Latest Solutions for Infrastructure Sector
 • Discussion on "Shifting focus from Established Markets to Global Markets"
 • Panel Discussion on:"Successful EPC Business Scenario with Respect to Indian Conditions"
 • CEO’s Panel on Preparing for Future and Excellence in Delivering EPC / Infrastructure Projects
 • Key Legal and Regulatory Issues
 • Key Environmental Issues
 • Risk Management
 • Project Financing - Opportunities and Challenges in current Economic Scenario

 For more information kindly visit :  http://www.companyprofilesandconferences.com/seminars-conferences/Manufacturing-Construction-c24/Middle-East-Engineering-Procurement-Construction-Conference-2012.html                           

 Or

 Contact us at :

 Company Profiles And Conferences
 Phone : +91 22 27810772 / 27810773
 Fax : + 91 22 27812290
 E-mail : info@companyprofilesandconferences.com
 Website : www.companyprofilesandconferences.com

2nd Annual Asian LTE Summit 2012 2nd Annual Asian LTE Summit 2012

CompanyProfileandconferences.com promote a new conference on "2nd Annual Asian LTE Summit 2012" discuss on Challenges and upcoming opportunities of LTE Business.

 2nd Annual Asian LTE Summit 2012 To be held on 12th Dec 2012 at Eros Hilton Hotel, (Nehru Place), New Delhi, India

 Over the last two decades, the way people communicate, stay informed, and are entertained has changed dramatically. There have been two major technologies driving this change – the Internet and mobile wireless communication. Now, these two forces are merging to enable the mobile Internet and the corresponding growth of mobile data services. India’s Long Term Evolution is very much in-shape & it is the future of next generation technology and it is the fastest mounting next generation mobile technology and industry is heavily committed to commercially launch this technology shortly. LTE has gained support from major mobile operators around the world. Out of 110 networks in Asia Pacific, 10 operators (9 percent) have started commercial 4G LTE business. According to a research Another 58 (53 percent) either have specific plans to roll out LTE or are conducting trials, 63 percent of Asia's telecom operators have rolled out LTE 4G, are conducting trials, or have announced plans. Despite challenges, Indian operators are executing a number of initiatives. http://www.companyprofilesandconferences.com/seminars-conferences/2nd-Annual-Asian-LTE-Summit-2012.html

 LTE is expected to provide multi-megabit bandwidth, more efficient use of the radio network, latency reduction, and improved mobility. This is expected to enhance subscriber interaction with the network and further drive the demand for mobile multimedia services. With wireless broadband, people can access Internet services, such as on-line television, blogging, social networking, and interactive gaming easily on the go.

 KEY THEMES DISCUSSED AT THIS CONFERENCE:-

 • Evaluating LTE launch & developing marketing strategies to achieve optimum revenue in Asia
 • Challenges and upcoming opportunities of LTE facing towards 2015
 • Identifying the best multimedia core solutions to deliver an optimum user experience and build an efficient network.
 • Identifying the newest technologies and market trends in LTE.
 • How the current Communications intend to take advantage of the LTE Opportunity
 • Examining the migration strategies that operators can implement
 • Challenges for the operators to migrate their networks from 3G to LTE and in which way can LTE produce more profits than current 3G technologies?
 • Identifying the key focus areas to influence the rural masses to make use of LTE
 • Current update from operators perspectives on LTE and their preparation for the next 12 months
 • Spectrum license for LTE and the various regulations and its surrounding
 • How can the present infrastructure be re-used for LTE at the lowest cost?
 • How LTE will be the technology of choice to bring broadband to the masses
 • How will 4G networks continue to evolve and how will converged 4g life look like?
 • Identifying the explosion in cloud services and the impact on LTE networks
 • How to enhance the subscriber’s interaction with the future network and further drive the demand for mobile multimedia services.
 • How can telecoms service providers and vendors in India maintain and increase profitability as subscription growth slows and data services expand?
 • Finding the successful LTE business models & investment opportunities for LTE
 • Interesting case studies and lessons to be learned from other successful Asian markets
 • Examining the LTE service plans for the end users.
 • Recognizing the main organizers in the world market - Roll of LTE amongst the mobile networks
 • Be part of a major networking opportunity

 For more information kindly visit :  http://www.companyprofilesandconferences.com/seminars-conferences/2nd-Annual-Asian-LTE-Summit-2012.html                           

 Or

 Contact us at :

 Company Profiles And Conferences
 Phone : +91 22 27810772 / 27810773
 Fax : + 91 22 27812290
 E-mail : info@companyprofilesandconferences.com
 Website : www.companyprofilesandconferences.com